SEC Form 4 · accession 0001547522-17-000042
IMMUCELL CORP /DE/ · ICCC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael F Brigham
Officer — President & CEO · Director
Period of report
Mar 17, 2017
Accepted (ET)
Mar 21, 2017 · 2:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811641
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.10 per share | Mar 17, 2017 | M | 1,000 | $5.25 | A | 157,252 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Options (Right to buy) | $5.25 | Mar 17, 2017 | M | 1,000 | D | Mar 19, 2010 | Mar 19, 2017 | Common Stock | 1,000 | 0 | D |